Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joshua Meyer, MD
Fox Chase Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tampa General Hospital
Tampa, Florida, United States
Timothy Nywening, MDNot, yet, recruiting - Rush University Cancer Center
Chicago, Illinois, United States
Completed - Advocate Christ Medical Center
Oak Lawn, Illinois, United States
Marc Mesleh, MDPaul Crossan, MDRecruiting - University Medical Center Lsu
New Orleans, Louisiana, United States
Completed - Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Completed - Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, United States
Completed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2017
- Primary completion
- 29 Oct 2027
- Completion
- 30 Oct 2028
- Last update posted
- 17 Jun 2025
- Registered enrollment
- 80
- Registry id
- NCT02843945
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.